Millennium Management’s Medifast MED Stock Holding History

Millennium Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,000	Closed	-$705K	–	6193
2024 Q4	$705K	Buy	+40,000	New	+$742K	﹤0.01%	4474
2024 Q2	–	Sell	-40,000	Closed	-$1.53M	–	6283
2024 Q1	$1.53M	Buy	+40,000	New	+$1.94M	﹤0.01%	3957
2023 Q3	–	Sell	-20,000	Closed	-$1.84M	–	6375
2023 Q2	$1.84M	Buy	20,000 +10,000	+100%	+$890K	﹤0.01%	3557
2023 Q1	$1.04M	Buy	10,000 +5,000	+100%	+$554K	﹤0.01%	4062
2022 Q4	$577K	Buy	5,000 +3,000	+150%	+$349K	﹤0.01%	4631
2022 Q3	$217K	Buy	+2,000	New	+$287K	﹤0.01%	5606
2022 Q1	–	Sell	-3,000	Closed	-$628K	–	7245
2021 Q4	$628K	Buy	+3,000	New	+$620K	﹤0.01%	4844
2019 Q4	–	Sell	-5,000	Closed	-$518K	–	4476
2019 Q3	$518K	Buy	5,000 +3,000	+150%	+$322K	﹤0.01%	3235
2019 Q2	$257K	Buy	+2,000	New	+$278K	﹤0.01%	3618

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management's MED Position: Q3 2025 in Review

Millennium Management sold out of Medifast (MED) in Q3 2025, closing a stake of 92,741 shares — an estimated $1.3M sold.

Millennium Management first reported a position in MED in Q2 2013 and held it in 47 quarters. The position peaked at $41.3M in Q1 2023. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

Millennium Management reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 92,741 Medifast shares in Q3 2025, an estimated $1.3M.
Millennium Management first reported a position in Medifast in Q2 2013 and held it in 47 quarters.
Millennium Management's Medifast position peaked at $41.3M in Q1 2023.
123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.